Core Laboratories (CLB)
(Delayed Data from NYSE)
$19.83 USD
+0.02 (0.10%)
Updated Jul 1, 2022 04:00 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Company Summary
Founded in 1936, Amsterdam, Netherlands-based Core Laboratories N.V. is an oilfield services company, operating in more than 50 countries. The firm deals with providing reservoir management and production enhancement services to the oil and gas companies. Geographically, the company has its operations in the United States, Europe, Africa, Middle East, Asia Pacific, Canada, Russia, Latin/South America. Notably, Core Labs generated revenues of $470.3 million in 2021.
While Core Labs provide different services and products for enhanced reservoir performance and oil/gas recovery, services accounted for 73% of the company’s sales in 2021. Product ...
Company Summary
Founded in 1936, Amsterdam, Netherlands-based Core Laboratories N.V. is an oilfield services company, operating in more than 50 countries. The firm deals with providing reservoir management and production enhancement services to the oil and gas companies. Geographically, the company has its operations in the United States, Europe, Africa, Middle East, Asia Pacific, Canada, Russia, Latin/South America. Notably, Core Labs generated revenues of $470.3 million in 2021.
While Core Labs provide different services and products for enhanced reservoir performance and oil/gas recovery, services accounted for 73% of the company’s sales in 2021. Product sales constituted 27% of the revenues. The company operates in two principal business lines: Reservoir Description and Product Enhancement.
The Reservoir Description segment is responsible for analyzing core samples of reservoir rocks for energy explorers ahead of the production. The collected data enables the producers to better understand the quantity and quality of hydrocarbons present. Accordingly, the explorers can determine the best ways to develop the fields so that they can maximize their output. This laboratory-based procedure helps in determining the rates at which oil and gas can be produced from the reservoir. Most of the firm's clients in this segment are non-US. During 2021, the Reservoir Description segment generated approximately 67% of the company’s revenues.
The Product Enhancement segment is engaged in helping operators increase oilfield recovery. It helps the oil and gas producers in well completions to increase recovery and extend the production life of the field. The company uses hydraulic fracturing and enhanced oil recovery methods to boost its output. The scope of the work also includes to adopt effective techniques to minimize the damage to the formation while bolstering the output. A vast majority of Core Laboratories’ Product Enhancement products are patented. This segment contributed 33% of revenues in 2021.
As of Dec 31, 2021, Core Laboratories had cash and cash equivalents worth $17.7 million and long-term debt of $188.6 million. The company’s debt-to-capitalization was 54%.
General Information
Core Laboratories NV
VAN HEUVEN GOEDHARTLAAN 7 B 1181 LE
AMSTELVEEN, P7 1077 XX
Phone: 31-20-420-3191
Fax: NA
Email: investor.relations@corelab.com
| Industry | Oil and Gas - Field Services |
| Sector | Oils-Energy |
| Fiscal Year End | December |
| Last Reported Quarter | 6/30/2022 |
| Earnings Date | 7/27/2022 |
EPS Information
| Current Quarter EPS Consensus Estimate | 0.14 |
| Current Year EPS Consensus Estimate | 0.69 |
| Estimated Long-Term EPS Growth Rate | NA |
| Earnings Date | 7/27/2022 |
Price and Volume Information
| Zacks Rank |  |
| Yesterday's Close | 19.81 |
| 52 Week High | 39.11 |
| 52 Week Low | 18.41 |
| Beta | 2.74 |
| 20 Day Moving Average | 425,587.25 |
| Target Price Consensus | 25.30 |
| 4 Week | -33.41 |
| 12 Week | -41.02 |
| YTD | -11.12 |
| 4 Week | -28.48 |
| 12 Week | -30.80 |
| YTD | 11.80 |
| Shares Outstanding (millions) | 46.31 |
| Market Capitalization (millions) | 918.28 |
| Short Ratio | NA |
| Last Split Date | 7/9/2010 |
| Dividend Yield | 0.20% |
| Annual Dividend | $0.04 |
| Payout Ratio | 0.06 |
| Change in Payout Ratio | -0.59 |
| Last Dividend Payout / Amount | 5/6/2022 / $0.01 |
Fundamental Ratios
| P/E (F1) | 28.74 |
| Trailing 12 Months | 30.98 |
| PEG Ratio | NA |
| vs. Previous Year | -46.67% |
| vs. Previous Quarter | -60.00% |
| vs. Previous Year | 6.38% |
| vs. Previous Quarter | -7.86% |
| Price/Book | 5.52 |
| Price/Cash Flow | 17.73 |
| Price / Sales | 1.92 |
| 6/30/22 | NA |
| 3/31/22 | 18.28 |
| 12/31/21 | 21.03 |
| 6/30/22 | NA |
| 3/31/22 | 5.00 |
| 12/31/21 | 5.57 |
| 6/30/22 | NA |
| 3/31/22 | 2.03 |
| 12/31/21 | 2.08 |
| 6/30/22 | NA |
| 3/31/22 | 1.54 |
| 12/31/21 | 1.58 |
| 6/30/22 | NA |
| 3/31/22 | 6.16 |
| 12/31/21 | 6.96 |
| 6/30/22 | NA |
| 3/31/22 | 2.04 |
| 12/31/21 | 4.20 |
| 6/30/22 | NA |
| 3/31/22 | 4.78 |
| 12/31/21 | 7.68 |
| 6/30/22 | NA |
| 3/31/22 | 3.59 |
| 12/31/21 | 3.48 |
| 6/30/22 | NA |
| 3/31/22 | 8.62 |
| 12/31/21 | 8.78 |
| 6/30/22 | NA |
| 3/31/22 | 1.14 |
| 12/31/21 | 1.17 |
| 6/30/22 | NA |
| 3/31/22 | 53.29 |
| 12/31/21 | 53.95 |